Filing Flows › Comparisons › EBRCZ vs IVF
EBR Systems vs Invo Fertility: EBRCZ and IVF compared
EBR Systems is the larger company: $2.5M of revenue in its latest quarter (Q3 2026) against $2.2M for Invo Fertility (Q2 2026). EBR Systems is growing faster (+386% against +17% a year earlier). Invo Fertility is more profitable, with an operating margin of -59.3% against -653.3%.
Where the money goes: EBRCZ and IVF
EBR Systems (EBRCZ) · Q3 2026
EBR Systems, Q3 2026: revenue $2.5M (+386% year over year), operating margin -653.3%, net loss $16.6M, operating cash flow −$17.3M. The chart follows the revenue to costs, profit and cash.
Invo Fertility (IVF) · Q2 2026
Invo Fertility, Q2 2026: revenue $2.2M (+17% year over year), operating margin -59.3%, net earnings $889K, operating cash flow −$1.1M. The chart follows the revenue to costs, profit and cash.
| EBR Systems (EBRCZ) | Invo Fertility (IVF) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q2 2026 |
| Revenue | $2.5M | $2.2M |
| Revenue growth, Y/Y | +386% | +17% |
| Operating margin | -653.3% | -59.3% |
| Net earnings | −$16.6M | $889K |
| Net margin | -669.2% | 40.9% |
| Operating cash flow | −$17.3M | −$1.1M |
Where the revenue comes from
EBR Systems
- WiSE CRT System: $2.5M (99%)
- Battery replacements: $33K (1%)
Invo Fertility
- Clinic Revenue: $2.2M (100%)
- Product: $8K (0%)
Questions
Which is bigger, EBR Systems or Invo Fertility?
EBR Systems is the larger company: $2.5M of revenue in its latest quarter (Q3 2026) against $2.2M for Invo Fertility (Q2 2026).
Is EBR Systems or Invo Fertility growing faster?
EBR Systems is growing faster (+386% against +17% a year earlier).
Which is more profitable, EBR Systems or Invo Fertility?
Invo Fertility is more profitable, with an operating margin of -59.3% against -653.3%.
More: EBR Systems earnings · how EBR Systems makes money · Invo Fertility earnings · how Invo Fertility makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 9, 2026; 10-Q filed Aug 14, 2026). Fiscal quarters can end on different dates. Not investment advice.